製品の概要

  • 製品名

    SD 169, ATP-competitive p38alpha MAPK inhibitor
  • 製品の詳細

    Potent, selective and ATP-competitive p38α MAPK inhibitor
  • 生理活性の詳細

    Potent, selective and ATP-competitive p38α MAPK inhibitor (IC50 values are 3.2 and 122 nM for α and β, respectively). Orally active. Promotes axonal regeneration in vivo.
  • 精製度

    > 99%
  • CAS 番号

    1670-87-7
  • 構造式

    Chemical Structure

製品の特性

参考文献

This product has been referenced in:

  • Medicherla S  et al. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes. J Pharmacol Exp Ther 318:99-107 (2006). Read more (PubMed: 16603672) »
  • Myers RR  et al. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 184:606-14 (2003). Read more (PubMed: 14769353) »

レビューと Q&A

There are currently no Customer reviews or Questions for ab120836.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

登録